These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28187048)

  • 21. The predictive ability of the CHADS2 and CHA2DS2-VASc scores for bleeding risk in atrial fibrillation: the MAQI(2) experience.
    Barnes GD; Gu X; Haymart B; Kline-Rogers E; Almany S; Kozlowski J; Besley D; Krol GD; Froehlich JB; Kaatz S
    Thromb Res; 2014 Aug; 134(2):294-9. PubMed ID: 24929840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.
    John R; Kamdar F; Liao K; Colvin-Adams M; Miller L; Joyce L; Boyle A
    J Thorac Cardiovasc Surg; 2008 Nov; 136(5):1318-23. PubMed ID: 19026822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the Outcomes of Acute Ischemic Stroke with Rheumatic Heart Disease: The Values of CHADS2, CHA2DS2-VASc, and HAS-BLED Scores.
    Liu J; Wang D; Tan G; Yuan R; Xu M; Xiong Y; Liu M
    J Stroke Cerebrovasc Dis; 2016 Mar; 25(3):722-6. PubMed ID: 26774873
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic assessment of CHA
    Serna MJ; Rivera-Caravaca JM; López-Gálvez R; Soler-Espejo E; Lip GYH; Marín F; Roldán V
    Rev Esp Cardiol (Engl Ed); 2024 Mar; ():. PubMed ID: 38460882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.
    Chan YH; Wu LS; Chang SH; Lee HF; Liu JR; See LC; Yeh YH; Kuo CT
    PLoS One; 2016; 11(3):e0151485. PubMed ID: 26986069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of the CHA
    Hong C; Alluri K; Shariff N; Khattak F; Adelstein E; Jain S; Saba S
    Am J Cardiol; 2017 Jul; 120(1):83-86. PubMed ID: 28479166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation of red blood cell distribution width with CHADS
    Liu T; Shao Q; Korantzopoulos P; Miao S; Zhang Z; Xu G; Yuan R; Li G
    Int J Cardiol; 2017 Feb; 228():861-864. PubMed ID: 27889552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
    Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
    Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors of thromboembolism in nonvalvular atrial fibrillation patients with low CHA2DS2-VASc score.
    Yan S; Li Q; Xia Z; Yan S; Wei Y; Hong K; Wu Y; Li J; Cheng X
    Medicine (Baltimore); 2019 Feb; 98(8):e14549. PubMed ID: 30813164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Weighing the risks: Thrombotic and bleeding events in adults with atrial arrhythmias and congenital heart disease.
    Heidendael JF; Bokma JP; de Groot JR; Koolbergen DR; Mulder BJ; Bouma BJ
    Int J Cardiol; 2015; 186():315-20. PubMed ID: 25838183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of Atrial Fibrillation on In-Hospital Mortality and Thromboembolic Complications after Left Ventricular Assist Device Implantation.
    Blumer V; Ortiz Bezara M; Kittipibul V; Greene SJ; Fudim M; Hernandez GA; Chaparro S; Joyce E
    J Cardiovasc Transl Res; 2021 Feb; 14(1):120-124. PubMed ID: 32076994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significantly higher rates of gastrointestinal bleeding and thromboembolic events with left ventricular assist devices.
    Shrode CW; Draper KV; Huang RJ; Kennedy JL; Godsey AC; Morrison CC; Shami VM; Wang AY; Kern JA; Bergin JD; Ailawadi G; Banerjee D; Gerson LB; Sauer BG
    Clin Gastroenterol Hepatol; 2014 Sep; 12(9):1461-7. PubMed ID: 24480675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio.
    Bhatia A; Juricek C; Sarswat N; Adatya S; Kim G; Sayer G; Ota T; Jeevanandam V; Uriel N
    ASAIO J; 2018; 64(2):140-146. PubMed ID: 28661909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative atrial fibrillation may not increase thromboembolic events in left ventricular assist device recipients on midterm follow-up.
    Xia Y; Stern D; Friedmann P; Goldstein D
    J Heart Lung Transplant; 2016 Jul; 35(7):906-12. PubMed ID: 27132796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHA
    Peacock WF; Tamayo S; Patel M; Sicignano N; Hopf KP; Yuan Z
    Ann Emerg Med; 2017 May; 69(5):541-550.e1. PubMed ID: 27913059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score?
    Ruiz-Nodar JM; Marín F; Roldán V; Valencia J; Manzano-Fernández S; Caballero L; Hurtado JA; Sogorb F; Valdés M; Lip GY
    Circ Cardiovasc Interv; 2012 Aug; 5(4):459-66. PubMed ID: 22787018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impact of atrial fibrillation in patients with the HeartMate II left ventricular assist device.
    Enriquez AD; Calenda B; Gandhi PU; Nair AP; Anyanwu AC; Pinney SP
    J Am Coll Cardiol; 2014 Nov; 64(18):1883-90. PubMed ID: 25444141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationship Between Anticoagulation Intensity and Thrombotic or Bleeding Outcomes Among Outpatients With Continuous-Flow Left Ventricular Assist Devices.
    Nassif ME; LaRue SJ; Raymer DS; Novak E; Vader JM; Ewald GA; Gage BF
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27154497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device.
    Meyer AL; Malehsa D; Budde U; Bara C; Haverich A; Strueber M
    JACC Heart Fail; 2014 Apr; 2(2):141-5. PubMed ID: 24720921
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.